Premium
Anticoagulation with heparin The art of simplicity even in patients on dialysis
Author(s) -
Belardi Jorge A.,
Albertal Mariano
Publication year - 2017
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27358
Subject(s) - medicine , bivalirudin , conventional pci , heparin , dialysis , observational study , regimen , intensive care medicine , anticoagulant , cardiology , myocardial infarction
Key Points In current PCI practice, anticoagulation with either bivalirudin or unfractionated heparin in patients with ACS share comparable efficacy and safety. Nonetheless, their individual performance in patients on dialysis remains unclear. This observational PCI study reported in‐hospital clinical outcome in patients on dialysis undergoing PCI according to drug regimen: bivalirudin versus heparin. Similar clinical outcome was observed with both drug regimens.